OraSure Technologies to Present at the Cowen & Company 34th Annual Health Care Conference
26 Febbraio 2014 - 12:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that
Douglas A. Michels, President and CEO, will speak to the investment
community at the Cowen & Co. 34th Annual Health Care Conference
in Boston, Massachusetts. The conference will be simultaneously
webcast over the Internet.
Mr. Michels is scheduled to speak March 5, 2014, at
approximately 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time).
Interested investors can access the live webcast of the
presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link. A replay
of the webcast will be available on OraSure Technologies' web site
for seven days. Alternatively, you can access the live webcast of
the presentation via the following link
http://wsw.com/webcast/cowen16/OSUR.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. The Company
sells the OraQuick® In-Home HIV Test, the first and only rapid HIV
test approved by the U.S. Food and Drug Administration for sale to
the consumer over-the-counter market in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection,
stabilization and preparation products for molecular diagnostic
applications. OraSure's portfolio of products is sold globally to
various clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research and
academic institutions, distributors, government agencies,
physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health.
For more information on the Company, please go to
www.orasure.com.
CONTACT: Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024